Coming to Terms with your Term Sheet

Thomas E. Duley is of counsel in Morgan Lewis' Business andFinance Practice. Mr. Duley has more than 10 years of experience in life sciences transactions and intellectual property litigation matters. He has negotiated, drafted, and managed a variety of intellectual property
transactions for life sciences companies, including collaboration
agreements between biotechnology and pharmaceutical companies, licensing agreements with commercial businesses and academicinstitutions, supply and manufacturing agreements, and asset purchases and sales involving drug products and manufacturing facilities. He has
overseen real estate and construction contracts, and guided and implemented formal contracting policies in compliance with Sarbanes-
Oxley regulations. Mr. Duley received his J.D. from UC Davis and a Master of Architecture degree from UCLA.

Gilbert R. Mintz, Ph.D. is President of GRM Associates, a biotechnology business development, licensing and strategic planning consulting firm. He specializes in building early-stage companies by focusing their strategic planning and licensing activities, and raising money through venture capitalists. His 25-plus years in the biotechnology industry include executive level business development roles and general and laboratory management. He has negotiated and closed over 400 deals for various clients involving technology platforms, corporate and academic collaborations; in/out licensing of late-stage products for partnerships worldwide; served as the President and CEO, Director of an early-stage cancer company; and provided transactional and strategic planning advice to numerous pre-IPO biotechnology companies. He received his Ph.D. from Washington University (St. Louis) and was a postdoc at Johns Hopkins University.